Cravath’s New York Office Moves to Two Manhattan West
Christopher J. Kelly has a broad banking practice, with experience in syndicated lending, finance and related matters for both financial lending institutions and corporate borrowers.
Mr. Kelly’s representative matters have included:
Mr. Kelly was born in Mount Kisco, New York. He received a B.A. summa cum laude from Columbia University in 1996, where he was elected to Phi Beta Kappa, and a J.D. from Harvard Law School in 1999, where he was Supervising Editor of the Journal on Legislation.
Mr. Kelly joined Cravath in 1999 and was elected a partner in 2022.
Mr. Kelly’s representative matters have included:
Mr. Kelly was born in Mount Kisco, New York. He received a B.A. summa cum laude from Columbia University in 1996, where he was elected to Phi Beta Kappa, and a J.D. from Harvard Law School in 1999, where he was Supervising Editor of the Journal on Legislation.
Mr. Kelly joined Cravath in 1999 and was elected a partner in 2022.
American Bar Association
Deals & Cases
June 24, 2024
On June 24, 2024, Illumina, Inc. (“Illumina”), a global leader in DNA sequencing and array-based technologies, announced the successful completion of the spin-off of GRAIL, a healthcare company whose mission is to detect cancer early. This follows Illumina’s previously announced plans to divest GRAIL, and GRAIL is now a public and independent company. The separation was achieved through the distribution of 85.5% of the outstanding shares of GRAIL to holders of Illumina common stock on June 24, 2024. In addition to retaining their shares of Illumina common stock, Illumina shareholders received one share of GRAIL common stock for every six shares of Illumina stock held as of close of business on the record date of June 13, 2024. Illumina retained 14.5% of the outstanding shares of GRAIL common stock. Cravath represented Illumina in connection with the transaction.
Deals & Cases
May 07, 2024
On May 7, 2024, Ashland Inc. (“Ashland”), a global additives and specialty ingredients company, announced that it has signed a definitive agreement to sell its nutraceuticals business to Turnspire Capital Partners LLC. Cravath is representing Ashland in connection with the transaction.
Deals & Cases
December 18, 2023
On December 18, 2023, ZimVie Inc. (“ZimVie”), a global life sciences leader in the dental and spine markets, announced it has entered into a definitive agreement to sell its spine business to H.I.G. Capital, a leading global alternative investment firm. Under the terms of the agreement, upon the closing of the transaction, ZimVie will receive $375 million in total consideration, comprised of $315 million in cash, subject to certain customary adjustments as set forth in the agreement, and $60 million in the form of a promissory note that will accrue interest at a rate of 10% per annum, compounded semi‑annually, payable in kind. Cravath is representing ZimVie in connection with the transaction.
Deals & Cases
October 23, 2023
On October 23, 2023, OUTFRONT Media Inc. (“OUTFRONT Media”) and Bell Media announced that they have entered into an agreement to sell the Canadian business of OUTFRONT Media to Bell Media, a wholly‑owned subsidiary of BCE. The purchase price is C$410 million in cash, subject to certain adjustments and a holdback. Cravath is representing OUTFRONT Media in connection with the transaction.
Deals & Cases
September 12, 2023
On September 12, 2023, the Boards of WestRock and Smurfit Kappa announced the signing of a definitive transaction agreement to create Smurfit WestRock, a global leader in sustainable packaging. Together, Smurfit Kappa and WestRock generated combined last twelve months’ adjusted annual revenue of approximately $34 billion as of June 30, 2023. Cravath is representing WestRock in connection with the transaction.
Firm News
November 16, 2022
Cravath has elected eight new partners. They are:
Christopher J. Kelly has a broad banking practice, with experience in syndicated lending, finance and related matters for both financial lending institutions and corporate borrowers.
Mr. Kelly’s representative matters have included:
Mr. Kelly was born in Mount Kisco, New York. He received a B.A. summa cum laude from Columbia University in 1996, where he was elected to Phi Beta Kappa, and a J.D. from Harvard Law School in 1999, where he was Supervising Editor of the Journal on Legislation.
Mr. Kelly joined Cravath in 1999 and was elected a partner in 2022.
Mr. Kelly’s representative matters have included:
Mr. Kelly was born in Mount Kisco, New York. He received a B.A. summa cum laude from Columbia University in 1996, where he was elected to Phi Beta Kappa, and a J.D. from Harvard Law School in 1999, where he was Supervising Editor of the Journal on Legislation.
Mr. Kelly joined Cravath in 1999 and was elected a partner in 2022.
American Bar Association
Deals & Cases
June 24, 2024
On June 24, 2024, Illumina, Inc. (“Illumina”), a global leader in DNA sequencing and array-based technologies, announced the successful completion of the spin-off of GRAIL, a healthcare company whose mission is to detect cancer early. This follows Illumina’s previously announced plans to divest GRAIL, and GRAIL is now a public and independent company. The separation was achieved through the distribution of 85.5% of the outstanding shares of GRAIL to holders of Illumina common stock on June 24, 2024. In addition to retaining their shares of Illumina common stock, Illumina shareholders received one share of GRAIL common stock for every six shares of Illumina stock held as of close of business on the record date of June 13, 2024. Illumina retained 14.5% of the outstanding shares of GRAIL common stock. Cravath represented Illumina in connection with the transaction.
Deals & Cases
May 07, 2024
On May 7, 2024, Ashland Inc. (“Ashland”), a global additives and specialty ingredients company, announced that it has signed a definitive agreement to sell its nutraceuticals business to Turnspire Capital Partners LLC. Cravath is representing Ashland in connection with the transaction.
Deals & Cases
December 18, 2023
On December 18, 2023, ZimVie Inc. (“ZimVie”), a global life sciences leader in the dental and spine markets, announced it has entered into a definitive agreement to sell its spine business to H.I.G. Capital, a leading global alternative investment firm. Under the terms of the agreement, upon the closing of the transaction, ZimVie will receive $375 million in total consideration, comprised of $315 million in cash, subject to certain customary adjustments as set forth in the agreement, and $60 million in the form of a promissory note that will accrue interest at a rate of 10% per annum, compounded semi‑annually, payable in kind. Cravath is representing ZimVie in connection with the transaction.
Deals & Cases
October 23, 2023
On October 23, 2023, OUTFRONT Media Inc. (“OUTFRONT Media”) and Bell Media announced that they have entered into an agreement to sell the Canadian business of OUTFRONT Media to Bell Media, a wholly‑owned subsidiary of BCE. The purchase price is C$410 million in cash, subject to certain adjustments and a holdback. Cravath is representing OUTFRONT Media in connection with the transaction.
Deals & Cases
September 12, 2023
On September 12, 2023, the Boards of WestRock and Smurfit Kappa announced the signing of a definitive transaction agreement to create Smurfit WestRock, a global leader in sustainable packaging. Together, Smurfit Kappa and WestRock generated combined last twelve months’ adjusted annual revenue of approximately $34 billion as of June 30, 2023. Cravath is representing WestRock in connection with the transaction.
Firm News
November 16, 2022
Cravath has elected eight new partners. They are:
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.